DIAGNOSE BASED ON DIRECT ACTIVE PATHOGEN DETECTION
Our analytical validation has indicated that CSI-Dx™ is a highly sensitive and specific test that accurately captures all positive results, including microbes associated with Lyme disease and other tick borne disease states. Our results are precise, and our analytical validation testing has revealed our limit of detection is 3 pathogenic cells per milliliter of urine. By providing accurate results quickly, physicians can diagnose their patients and create customized treatments specific to the active infection.
CSI-DX™ BENEFITS FOR PHYSICIANS AND PATIENTS
Identifying all of the infectious pathogens is just the start of how CSI-Dx™ can help physicians deliver the best possible patient care:
1. Quick, Accurate Data
Identify the presence of tickborne-associated bacteria and any contributing pathogens with one sample. After 24 hours of sample processing time physicians can receive clear, actionable results with diagnostic data necessary to present a firm diagnosis with a targeted treatment plan.
2. Smooth Process
Our proprietary laboratory processes keep test turn-around times low. Our customized LIMS platform ensures accurate and timely result delivery, and can automatically send results to your institution.
3. Satisfied Patients
CSI-Dx’s patented processes means patients can be treated earlier and more effectively with targeted treatment plans. With CSI-Dx™, you can deliver a quality of care that deepens your patients’ satisfaction, trust, and health.